Boundless Bio, Inc. (BOLD)
NASDAQ: BOLD · Real-Time Price · USD
1.140
+0.010 (0.88%)
Mar 9, 2026, 2:32 PM EDT - Market open
Boundless Bio Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Mar '26 Mar 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 26 | 27 | 65 | - | - | - |
| Market Cap Growth | -42.78% | -58.46% | - | - | - | - |
| Enterprise Value | -33 | -41 | -102 | - | - | - |
| Last Close Price | 1.13 | 1.20 | 2.90 | - | - | - |
| PB Ratio | 0.23 | 0.27 | 0.43 | - | - | - |
| P/TBV Ratio | 0.26 | 0.27 | 0.43 | - | - | - |
| Debt / Equity Ratio | 0.50 | 0.50 | 0.32 | 0.02 | 0.08 | 0.00 |
| Net Debt / Equity Ratio | -0.59 | -0.59 | -0.69 | -0.98 | -0.93 | -0.66 |
| Net Debt / EBITDA Ratio | 0.94 | 0.94 | 1.45 | 2.20 | 1.35 | 2.95 |
| Net Debt / FCF Ratio | 1.24 | 1.24 | 1.65 | 2.50 | 1.51 | 2.87 |
| Quick Ratio | 8.58 | 8.58 | 18.70 | 12.90 | 8.63 | 18.89 |
| Current Ratio | 8.74 | 8.74 | 18.98 | 13.27 | 8.80 | 19.28 |
| Return on Equity (ROE) | -46.69% | -46.69% | -48.21% | -52.93% | -52.16% | - |
| Return on Assets (ROA) | -21.86% | -21.86% | -27.23% | -33.13% | -30.48% | - |
| Return on Capital Employed (ROCE) | -44.00% | -44.00% | -37.00% | -45.50% | -67.20% | -23.00% |
| Earnings Yield | -231.10% | -216.66% | -101.08% | - | - | - |
| FCF Yield | -187.46% | -175.75% | -98.01% | - | - | - |
| Buyback Yield / Dilution | -31.65% | -31.65% | -1296.71% | -10.77% | -27.56% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.